Smith & Nephew plc vs Vanguard Ultra Short Bond ETF — how do they compare? Smith & Nephew plc trades at $30.05 (market cap $12.54B), while Vanguard Ultra Short Bond ETF trades at $49.67. The key difference: Smith & Nephew plc pays a 2.65% dividend while Vanguard Ultra Short Bond ETF pays none. Which is the better fit depends on your goals.
| SNN | VUSB | |
|---|---|---|
Market Cap | $12.54B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $38.70 | $50.03 |
52-Week Low | $28.73 | $49.60 |
Enterprise Value | $15.57B | — |
Dividend Yield | 2.65% | — |
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →